Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.
Weeks after closing Bristol Myers deal, Karuna’s ex-CEO heads to Blackstone-backed Anthos
How does Bill Meury celebrate a $14 billion merger? With a new post at a Blackstone-founded biotech. Meury has been appointed CEO at Anthos Therapeutics,